Pharmacological challenges in chronic pancreatitis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 42

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

663

HTML

4314

Figures (1-1)

287

Tables (1-1)

213

Sum=5477

Publishing Process of This Article

Item

Count

Browse

1295

Download

1174

Sum=2469

Nov 14, 2013 (publication date) through Nov 3, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Nov 14, 2013; 19(42): 7302-7307
Published online Nov 14, 2013. doi: 10.3748/wjg.v19.i42.7302

Table 1 Pathophysiological and lifestyle related effects on drug absorption

Pathophysiology	Effect on drug absorption
Low intraluminal pH	The drugs ability to cross the luminal wall
Motility disorder	Delayed drug effect
Bacterial overgrowth	Decreased absorption due to diarrhea or structural abnormalities
Pancreatic secretion	Lack of enzymes leads to inactivation of pro-drugs
Steatorrhea	Problems with absorption of lipophilic drugs
Low body mass index	Increased plasma concentration

Citation: Olesen AE, Brokjaer A, Fisher IW, Larsen IM. Pharmacological challenges in chronic pancreatitis. World J Gastroenterol 2013; 19(42): 7302-7307
URL: https://www.wjgnet.com/1007-9327/full/v19/i42/7302.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i42.7302